Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple Negative Breast Cancer Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06627712
What this trial is testing

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Who this might be right for
TNBC - Triple-Negative Breast Cancer
West China Hospital 318
Large-scale testing (Phase 3)Study completedNCT01881230
What this trial is testing

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

Who this might be right for
Breast TumorBreast CancerCancer of the Breast+8 more
Celgene 191
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05067530
What this trial is testing

Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study

Who this might be right for
Triple Negative Breast Neoplasms
Medical University of Gdansk 126
Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT02957968
What this trial is testing

Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca

Who this might be right for
Breast AdenocarcinomaEstrogen Receptor- Negative Breast CancerEstrogen Receptor-positive Breast Cancer+10 more
Virginia Commonwealth University 46
Testing effectiveness (Phase 2)Looking for participantsNCT07601178
What this trial is testing

QUEEN-APPLE: A Single-Arm, Multicenter, Prospective Phase II Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Anlotinib Hydrochloride and Nab-Paclitaxel as First-Line Treatment for Advanced Triple-Negative Breast Cancer

Who this might be right for
TNBC, Triple Negative Breast Cancer
Jiangsu Cancer Institute & Hospital 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT01898117
What this trial is testing

Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 304
Testing effectiveness (Phase 2)Looking for participantsNCT05846789
What this trial is testing

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Who this might be right for
Metastatic Breast CancerTriple Negative Breast CancerEstrogen-receptor-low Breast Cancer+1 more
Kathy Miller 168
Early research (Phase 1)Ended earlyNCT04726332
What this trial is testing

Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)

Who this might be right for
Neoplasm MalignantEpithelial Ovarian CancerTriple Negative Breast Cancer+2 more
Exelixis 52
Not applicableActive Not RecruitingNCT05955521
What this trial is testing

Exosome as the Prognostic and Predictive Biomarker in EBC Patients

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast Cancer
Samsung Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02513472
What this trial is testing

Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple-Negative Breast Cancer (mTNBC)

Who this might be right for
Breast Neoplasm
Eisai Inc. 258
Testing effectiveness (Phase 2)Looking for participantsNCT05490472
What this trial is testing

JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsER+ Breast CancerTriple Negative Breast Cancer, TNBC+2 more
Jacobio Pharmaceuticals Co., Ltd. 102
Testing effectiveness (Phase 2)Study completedNCT01289353
What this trial is testing

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
NYU Langone Health 92
Very early researchWithdrawnNCT04249167
What this trial is testing

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+9 more
Mayo Clinic
Early research (Phase 1)Study completedNCT04584112
What this trial is testing

The Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Hoffmann-La Roche 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05227664
What this trial is testing

AK117/AK112 in Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Triple-negative Breast CancerLocally Advanced Triple-negative Breast Cancer
Akeso 120
Testing effectiveness (Phase 2)Looking for participantsNCT03740893
What this trial is testing

PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer

Who this might be right for
Breast NeoplasmTriple Negative Breast Cancer (TNBC)HRD
Institute of Cancer Research, United Kingdom 119
Testing effectiveness (Phase 2)Looking for participantsNCT06926920
What this trial is testing

Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT02981303
What this trial is testing

Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

Who this might be right for
Advanced MelanomaTriple-Negative Breast Cancer
HiberCell, Inc. 64
Not applicableLooking for participantsNCT02302742
What this trial is testing

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Who this might be right for
Breast CancerHereditary Breast and Ovarian Cancer
University of Kansas Medical Center 3,000
Next Page